Data / Drug companies / Methylcellulose
Methylcellulose: 17 companies and 20 products in the FDA NDC directory
Methylcellulose is listed in the FDA National Drug Code Directory by 17 companies, with 20 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; powder, for solution, and the newest product started marketing on December 1, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 20
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Citrucel, Fiber Therapy, DRx Choice Fiber Therapy, Heb Fiber Therapy, CVS Fiber Therapy, Amazon Fiber Therapy, Soluble Fiber, Cdma Fiber Therapy
- openFDA record search
- api.fda.gov
Companies that list methylcellulose
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Haleon US Holdings LLC | 3 | powder, for solution; tablet | Over the counter monograph drugs | September 16, 2010 |
| Raritan Pharmaceuticals Inc | 2 | tablet; powder, for solution | Over the counter monograph drugs | July 20, 2022 |
| Amazon.com Services LLC | 1 | tablet | Over the counter monograph drugs | December 1, 2025 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | tablet | Over the counter monograph drugs | September 14, 2023 |
| Chain Drug Consortium, LLC | 1 | tablet | Over the counter monograph drugs | April 19, 2019 |
| Chain Drug Marketing Association | 1 | tablet | Over the counter monograph drugs | April 19, 2019 |
| Chain Drug Marketing Association, Inc. | 1 | tablet | Over the counter monograph drugs | September 20, 2024 |
| H E B | 1 | powder, for solution | Over the counter monograph drugs | April 25, 2019 |
| Major Pharmaceuticals | 1 | powder, for solution | Over the counter monograph drugs | April 18, 2008 |
| Meijer Distribution Inc | 1 | tablet | Over the counter monograph drugs | March 14, 2017 |
| Perrigo Direct, Inc | 1 | tablet | Over the counter monograph drugs | December 1, 2015 |
| Preferred Pharmaceuticals Inc. | 1 | powder, for solution | Over the counter monograph drugs | August 9, 2021 |
| Rite Aid Corporation | 1 | tablet | Over the counter monograph drugs | March 12, 2019 |
| United Natural Foods, Inc. DBA Unfi | 1 | tablet | Over the counter monograph drugs | August 24, 2018 |
| Valu Merchandisers Company | 1 | tablet | Over the counter monograph drugs | April 19, 2019 |
| Wal-Mart Stores Inc | 1 | tablet | Over the counter monograph drugs | August 30, 2017 |
| Walgreen Company | 1 | tablet | Over the counter monograph drugs | May 14, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 14 | 70% |
| Powder, for solution | 6 | 30% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 100% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.